Mostrar el registro sencillo del ítem

dc.contributor.authorde la Rubia Ortí, Jose Enrique
dc.contributor.authorPlatero Armero, José Luis
dc.contributor.authorSanchis-Sanchis, Claudia Emmanuela
dc.contributor.authorSancho-Castillo, Sandra
dc.contributor.authorSalazar Couso, Alejandro 
dc.contributor.authorCaplliure-Llopis, Jordi
dc.contributor.authorNavarro-Illana, Esther
dc.contributor.authorBarrios, Carlos
dc.contributor.authorEscribá-Alepuz, Jesús
dc.contributor.authorBenlloch, María
dc.contributor.otherEstadística e Investigación Operativaes_ES
dc.date.accessioned2021-06-15T08:12:04Z
dc.date.available2021-06-15T08:12:04Z
dc.date.issued2021-04
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/10498/24952
dc.description.abstractBackground: One of the pathogenic mechanisms of ALS disease is perturbed energy metabolism particularly glucose metabolism. Given the substantial difference in the severity and the prognosis of the disease, depending on whether it has a bulbar or spinal onset, the aim of the study was to determine metabolic differences between both types of ALS, as well as the possible relationship with muscle function. Materials and Methods: A descriptive, analytical, quantitative, and transversal study was carried out in hospitals and Primary Care centers in the region of Valencia, Spain. Fasting glucose and alkaline phosphatase (AP) levels in venous blood, muscle percentage, fat percentage, muscle strength (MRC scale), and functional capacity (Barthel Index) were measured in 31 patients diagnosed with ALS (20 with spinal onset ALS and 11 with bulbar onset ALS). A healthy control of 29 people was included. Results: No significant differences were observed in blood AP and glucose levels between spinal onset and bulbar onset ALS patients. However, a significant positive correlation was observed between the mean values of both substances in patients with spinal onset ALS. Moreover, a lower percentage of muscle mass and a higher percentage of fat mass were also seen in spinal ALS patients, who also presented lower muscle strength and lower functional capacity. Conclusion: The results of this study seem to point to a possible difference in the peripheral use of glucose between patients with bulbar onset ALS and spinal onset ALS, who appear to have possible insulin resistance. These metabolic differences could explain the lower muscle percentage and lower muscular function in spinal onset ALS patients, although further studies are required.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJ. Clin. Med. 2021, 10(8), 1582es_ES
dc.subjectamyotrophic lateral sclerosises_ES
dc.subjectglucosees_ES
dc.subjectalkaline phosphatasees_ES
dc.subjectspinal onset ALSes_ES
dc.subjectbulbar onset ALSes_ES
dc.titleMuscle Function Differences between Patients with Bulbar and Spinal Onset Amyotrophic Lateral Sclerosis. Does It Depend on Peripheral Glucose?es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/jcm10081582


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional